Cape Verde Launches Integrated Pharmaceutical Market Monitoring System
Cape Verde is now deploying the Integrated Pharmaceutical Market Monitoring System (SIMFAR), a digital platform designed to track the medicines market, control prices, and monitor stock levels in real time.
The system was launched by the Independent Health Regulatory Authority (ERIS) in Praia.
According to Eduardo Tavares, president of ERIS's board of administration, SIMFAR represents a structural shift in how Cape Verde's pharmaceutical market will be regulated.
"This is a particularly important moment for ERIS and for Cape Verde. Today we are not merely presenting a technological platform, but inaugurating a new way of knowing, understanding, and regulating our national pharmaceutical market. We take a firm step toward more modern, intelligent, transparent, and evidence-driven regulation — capable of anticipating challenges, supporting decisions, and creating value for the entire health ecosystem," he states.
Tavares emphasizes that the system will transform data into knowledge, strengthening the capacity to prevent problems and support decision-making based on reliable information.
"SIMFAR will allow us to continuously monitor the availability of essential medicines, track stock levels, track price changes, and identify risks to national market supply. The goal is to stop acting only when problems emerge and instead anticipate them, better protecting public health and making regulation more efficient and preventive," he notes.
For his part, State Secretary of Health Artur Veiga views the platform launch as a significant milestone in the digital transformation of the National Health System.
"SIMFAR represents an important milestone in the modernization of pharmaceutical regulation in Cape Verde. We live in a time when digital transformation has ceased to be an option and become an indispensable instrument for good governance. Decisions based on reliable, up-to-date, and integrated information translate into better public policies, greater transparency, and better protection of public health," he states.
According to the official, the initiative aligns with the government's priorities for strengthening data-driven governance and promoting integration of information systems in health.
SIMFAR is part of ERIS's digital transformation strategy for 2026–2028 and serves as a tool to support pharmaceutical policy definition, institutional planning, and strengthening the capacity to respond to potential medicine shortages or abnormal market shifts.
